Holen Sie sich die Stockscreener-App
1.54
5.48%
0.08
Handel nachbörslich:
1.20
-0.34
-22.08%
Schlusskurs vom Vortag:
$1.46
Offen:
$1.48
24-Stunden-Volumen:
9,838
Relative Volume:
0.90
Marktkapitalisierung:
$16.24M
Einnahmen:
$14.24M
Nettoeinkommen (Verlust:
$-1.58M
KGV:
-10.27
EPS:
-0.15
Netto-Cashflow:
$827.00K
1W Leistung:
+3.36%
1M Leistung:
-5.49%
6M Leistung:
-25.78%
1J Leistung:
-57.46%
1-Tages-Spanne:
$1.46
$1.54
1-Wochen-Bereich:
$1.45
$1.54
52-Wochen-Spanne:
$1.3643
$3.90
Nephros Inc Stock (NEPH) Company Profile
Firmenname
Nephros Inc
Sektor
Telefon
201.343.5202
Adresse
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Vergleichen Sie NEPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.29 | 612.00M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.65 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.82 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.01 | 129.62M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
3.65 | 47.48M | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-26 | Eingeleitet | B. Riley Securities | Buy |
Nephros Inc Aktie (NEPH) Neueste Nachrichten
Critical Analysis: Todos Medical (OTCMKTS:TOMDF) and Nephros (NASDAQ:NEPH) - Defense World
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC - The Manila Times
Nephros to Present at Benchmark's Discovery Investor Conference, CEO and CFO to Meet Key Investors - StockTitan
Nephros, Inc. (NASDAQ:NEPH) Q3 2024 Earnings Call Transcript - MSN
Nephros Inc (NEPH) Quarterly 10-Q Report - Quartzy
Results: Nephros, Inc. Confounded Analyst Expectations With A Surprise Profit - Yahoo Finance
Nephros Inc (NEPH) Q3 2024 Earnings Call Highlights: First Profi - GuruFocus.com
Nephros Inc (NEPH) Q3 2024 Earnings Call Highlights: First Profitable Quarter and Strategic ... - Yahoo Finance
Nephros, Inc. Reports First Profitable Quarter in 2024 - TipRanks
Nephros earnings beat by $0.04, revenue topped estimates - Investing.com UK
Nephros Achieves First Profitable Quarter Amid Operational Improvements - Citybuzz
Nephros Announces Financial Results for Quarter Ended September 30, 2024 - StockTitan
Nephros, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
What To Expect From Nephros Inc (NEPH) Q3 2024 Earnings - GuruFocus.com
Nephros Schedules Third Quarter 2024 Financial Results Conference Call - The Manila Times
Nephros launches HydraGuard 20″ UltraFilter - Yahoo Finance
Nephros Expands Market Reach with New HydraGuard 20″ UltraFilter - Vancity Buzz
Nephros Launches New HydraGuard 20” UltraFilter - The Manila Times
Nephros stock plunges to 52-week low of $1.43 amid market challenges - Investing.com Australia
Nephros stock plunges to 52-week low of $1.43 amid market challenges By Investing.com - Investing.com South Africa
Nephros helps hospitals and care facilities affected by Hurricanes Helene and Milton - Filtration + Separation
Nephros Provides Critical Water Filtration Solutions in Wake of Hurricanes Helene and Milton - Vancity Buzz
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton - The Manila Times
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes - EIN News
Nephros stock plunges to 52-week low of $1.45 amid market challenges By Investing.com - Investing.com South Africa
Nephros Inc (NEPH) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Nephros stock plunges to 52-week low of $1.45 amid market challenges - Investing.com
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH) - Simply Wall St
Medical Water Filter Market Size, Share, Growth and Industry Trends - Third Eye News
Nephros (NASDAQ:NEPH) Stock Price Down 0.7% - Defense World
Peritoneal Dialysis Market Trend and Global Demand 2024 to 2031 - Cineglit
Nephros Shares 2024 Corporate Outlook and Plans - TipRanks
Nephros (NASDAQ:NEPH) Shares Up 0.5% - Defense World
Nephros holds Speculative Buy rating, stock target despite 2Q miss - Investing.com
Nephros holds Speculative Buy rating, stock target despite 2Q miss By Investing.com - Investing.com UK
NEPH (Nephros) 3-Year Revenue Growth Rate : 13.30% (As of Jun. 2024) - GuruFocus.com
Earnings call: Nephros reports mixed Q2 2024 results, focuses on digital tools - Investing.com India
Nephros, Inc. (NASDAQ:NEPH) Q2 2024 Earnings Call Transcript - Insider Monkey
Nephros Second Quarter 2024 Earnings: Misses Expectations - Simply Wall St
US$4.75That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results - Yahoo Finance
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
Nephros Announces Financial Results for Quarter Ended June 30, 2024 - wallstreet:online
NEPH Stock Earnings: Nephros Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Nephros (NEPH) to Release Quarterly Earnings on Thursday - Defense World
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn - Yahoo Finance
Nephros Schedules Second Quarter 2024 Financial Results Conference Call - StockTitan
Nephros (NASDAQ:NEPH) Trading 0.5% Higher - Defense World
Finanzdaten der Nephros Inc-Aktie (NEPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nephros Inc-Aktie (NEPH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Amron Arthur H | Director |
May 28 '24 |
Buy |
2.22 |
2,000 |
4,441 |
100,463 |
| Banks Robert R. Jr. | President and CEO |
May 16 '24 |
Buy |
2.24 |
50,000 |
112,050 |
70,000 |
| Amron Arthur H | Director |
Mar 12 '24 |
Buy |
2.45 |
7,000 |
17,130 |
7,000 |
2.64%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):